相关实验视频
Updated: Jun 19, 2025
08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
3.7K
参与BOK的线粒可以缓解阿尔茨海默氏病的神经病理
Yang Yang1,2, Hui Chen3, Shuwen Huang2
1Research Centre, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
Brain : a journal of neurology
|July 26, 2024
概括
阿尔茨海默病涉及线粒体问题. 这项研究揭示了BOK蛋白调节线粒,通过清除受损的线粒体来改善认知功能,提供了一个新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 线粒体功能障碍和线粒体功能障碍有助于在阿尔茨海默氏病 (AD) 中的突触损失和认知衰退.
- 在AD动物模型中,促进线粒可以提高认知功能的潜力.
- 在阿尔茨海默氏症中控制线粒的精确调节机制在很大程度上仍然不清楚.
研究的目的:
- 为了阐明阿尔茨海默氏症中线粒的调节机制.
- 为了研究Bcl-2家族成员BOK在帕金介导线粒中的作用.
- 评估AD中调节BOK信号的治疗潜力.
主要方法:
- 在阿尔茨海默病患者和APP/PS1小鼠中分析BOK表达.
- 研究BOK,MCL1和Parkins在线粒中的相互作用.
- 在APP/PS1小鼠的海马神经元中调节BOK表达 (过度表达和淘汰).
- 评估线粒体功能,线粒体,突触完整性和认知表现.
主要成果:
- 在AD患者和APP/PS1小鼠中,神经元特异性BOK损失与线粒体损伤和线粒体缺陷相关.
- BOK通过竞争性结合MCL1作为帕金介导线粒的关键调节者,促进帕金转移到受损的线粒体.
- 在APP/PS1小鼠中,BOK的过度表达改善了线粒,线粒体功能和认知表现,而BOK的降低加剧了AD相关的病理.
结论:
- 博克在调节帕金斯介导的线粒中发挥着关键作用,为缓解AD病理提供了一种新的机制.
- 在阿尔茨海默病中,BOK信号传递代表了改善线粒体质量控制和认知功能的有前途的治疗标.
更多相关视频
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
455
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
01:27Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
01:36Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K